MedPath

Study on the effect of Qishe Pill on functional recovery of patients after Cervical surgery and its Mechanism of delaying Intervertebral Disc degeneratio

Phase 4
Recruiting
Conditions
Cervical spondylosis
Registration Number
ITMCTR2100004580
Lead Sponsor
Dongzhimen Hospital Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged 40 to 70 years old;
2. Preoperative compliance with the diagnostic criteria and surgical indications of cervical spondylosis;
3. Surgical treatment of cervical vertebrae (anterior approach) for the first time;
4. In line with the diagnostic criteria of TCM syndromes and the syndrome differentiation of qi deficiency and blood stasis;
5. The patients voluntarily joined the trial and signed the informed consent form.

Exclusion Criteria

1. Those who meet the above diagnostic criteria, but whose vital signs are not stable after operation;
2. Patients with severe primary diseases such as liver, kidney, hematopoietic system and endocrine system;
3. A woman who is breastfeeding or preparing for pregnancy;
4. Suspected or diagnosed with myelopathy and / or central nervous system diseases with changes in muscle tone (e.g. stroke, stroke sequelae, syringomyelia, muscular dystrophy, etc.);
5. Have received other relevant treatment, which may affect the observer of the effect index in this study;
6. Those who cannot tolerate or are allergic to treatment;
7. There are mental disorders that can't cooperate with researchers;
8. Other researchers believe that it is not appropriate for patients to participate in this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
JOA;
Secondary Outcome Measures
NameTimeMethod
SF-36;VAS;NDI;
© Copyright 2025. All Rights Reserved by MedPath